This protocol is judged by an institutional critique board, an independent team that reviews any clinical trials involving humans. If a analyze includes a Plan I drug, after the board approves the protocol as moral, the scientists really have to submit an application for an investigational new drug (IND) amount within the FDA.Access to illegal drug